Live Breaking News & Updates on Hagopm Kantarjian

Stay updated with breaking news from Hagopm kantarjian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Redefining Research Practices in Search of a Cure

Fernando Cabanillas, MD, a mentor and leader in the lymphoma field, is being recognized for his contributions to the hematologic oncology space. ....

Puerto-rico , South-africa , Spain , Irvine , California , United-states , Texas , America , Susanm-obrien , Perpetuo-socorro , Fernando-cabanillas , Hagopm-kantarjian

Advances in Ph+ ALL: Evolving Therapies and Future Strategies

Advances in Ph+ ALL: Evolving Therapies and Future Strategies
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Philadelphia , Pennsylvania , United-states , Hagopm-kantarjian , Bijald-shah ,

Optimizing Real-World Ponatinib Use in Ph+ ALL: Treatment Considerations

Insights on real-world ponatinib treatment strategies and safety in Philadelphia-positive acute lymphoblastic leukemia are provided by Hagop Kantarjian, MD, and Bijal D. Shah, MD, MS. ....

Hagopm-kantarjian , Bijald-shah , Acute-lymphoblastic-leukemia , Call-cancer , Oph-all , Ph-acute-lymphoblastic-leukemia , Philadelphia-chromosome-positive-acute-lymphoblastic-leukemia , Newly-diagnosed-all , Newly-diagnosed-acute-lymphoblastic-leukemia , Ponatinib-based-therapy , Ponatinib-safety

Early Cytogenetic or Molecular Landmark Response to Ponatinib Predicts Outcomes in CP-CML

Early cytogenetic and molecular responses achieved with ponatinib was significantly linked with better long-term progression-free survival and overall survival in patients with highly resistant, pretreated chronic-phase chronic myeloid leukemia. ....

Texas , United-states , Hagopm-kantarjian , Department-of-leukemia , University-of-texas-md-anderson-cancer-center , Samsung-distinguished-leukemia-chair , Cancer-medicine , Society-of-hematologic-oncology-annual-meeting-soho , Hematologic-oncology , Conference , Precision-medicine-in-oncology

Dr Kantarjian on the Predictive Value of Early Responses to Ponatinib in CP-CML

Hagop M. Kantarjian, MD, discusses the predictive value of early landmark cytogenetic or molecular responses to ponatinib in heavily pretreated patients with chronic-phase chronic myeloid leukemia. ....

Texas , United-states , Hagopm-kantarjian , Department-of-leukemia , University-of-texas-md-anderson-cancer-center , Samsung-distinguished-leukemia-chair , Cancer-medicine , Cancer-center , Soho-annual-meeting , Soho-2023 , Cp-cml